Photo from Diana Merino Vega/Linkedin
Jul 12, 2023, 19:33
ctDNA will enable earlier detection and tailored treatment modifications to improve patient outcomes – Diana Merino Vega
Thanks Friends of Cancer Research and my fellow panelists for a great discussion on the importance of measuring and interpreting the changes in ctDNA levels as an early indicator of long-term outcomes.
Ensuring that patients receive a personalized approach in their treatment management is essential and the advancements in technologies that improve ctDNA detection will enable this.
ctDNA will enable earlier detection and tailored treatment modifications to improve patient outcomes and save patients’ lives. It’s an exciting time in the world of liquid biopsy technologies and ctDNA analysis as they signal the opportunity to transform cancer care.
For more info on how we’re harnessing these advancements click here:
https://lnkd.in/ggPp263X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 14:06
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33